Investigating the clinical application and in vitro effect of regorafenib in advanced and metastatic melanoma and overcoming acquired resistance to targeted therapies.

Activiteit: Written proposal

Description

Written proposal for PhD Fellowship strategic basic research
Periode27 feb 2023